Overview

Safety and Preliminary Efficacy Study of V404 PDS in Uveitis

Status:
Terminated
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This study is intended to evaluate the safety of V404 PDS in patients with chronic non-infectious uveitis. Secondarily, the study will evaluate whether V404 PDS can provide clinically measurable benefit over an extended period of time in patients with chronic non-infectious uveitis.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Forsight Vision4
Treatments:
Methotrexate